Supplemental material
Drug Delivery
Volume 24, 2017 - Issue 1
Related Research Data
Suppression of LPS-induced inflammatory responses by gossypol in RAW 264.7 cells and mouse models
Source:
Elsevier BV
Enhanced delivery of α-glucosidase for Pompe disease by ICAM-1-targeted nanocarriers: comparative performance of a strategy for three distinct lysosomal storage disorders
Source:
Elsevier BV
The margination propensity of spherical particles for vascular targeting in the microcirculation
Source:
Springer Science and Business Media LLC
Vascular Targeting of Nanocarriers: Perplexing Aspects of the Seemingly Straightforward Paradigm
Source:
American Chemical Society (ACS)
Simvastatin Blunts Endotoxin-Induced Tissue Factor In Vivo
Source:
Ovid Technologies (Wolters Kluwer Health)
Cytoskeletal Activation and Altered Gene Expression in Endothelial Barrier Regulation by Simvastatin
Source:
American Thoracic Society
The Acute Respiratory Distress Syndrome: Pathogenesis and Treatment
Source:
Annual Reviews
Biomarkers of inflammation, coagulation and fibrinolysis predict mortality in acute lung injury
Source:
Springer Science and Business Media LLC
Transport pathways of solid lipid nanoparticles across Madin-Darby canine kidney epithelial cell monolayer.
Source:
American Chemical Society (ACS)
Advances in lipid-based colloid systems as drug carrier for topic delivery.
Source:
Elsevier BV
Dicloxacillin and erythromycin at high concentrations increase ICAM-1 expression by endothelial cells: a possible factor in the pathogenesis of infusion phlebitis
Source:
Oxford University Press (OUP)
A randomized clinical trial of hydroxymethylglutaryl-Coenzyme A reductase inhibition for Acute Lung Injury (The HARP study)
Source:
American Thoracic Society
The potential role of nano- and micro-technology in the management of critical illnesses.
Source:
Elsevier BV
Endothelium in vitro: a review of human vascular endothelial cell lines for blood vessel-related research.
Source:
Springer Science and Business Media LLC
Control of endothelial targeting and intracellular delivery of therapeutic enzymes by modulating the size and shape of ICAM-1-targeted carriers.
Source:
Elsevier BV
Combined delivery of HMGB-1 box A peptide and S1PLyase siRNA in animal models of acute lung injury.
Source:
Elsevier BV
Linking provided by
